You probably heard, as I did, particularly during the first hour, all kinds of numbers about the amount of money that the department is going to provide to rebuild the Canadian vaccine and biological products production industry. For the first phase, $900 million is the figure that was mentioned, and $1.3 billion for the second phase, for a total of $2.2 billion. So far, only $1.6 billion have been spent, leaving $600 million unspent.
How can this money be invested in the short term to make conditions attractive once again for the pharmaceutical industry?